4//SEC Filing
Jacobson Mark L. 4
Accession 0000950170-25-084556
CIK 0001579428other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 7:00 PM ET
Size
8.7 KB
Accession
0000950170-25-084556
Insider Transaction Report
Form 4
Jacobson Mark L.
Chief Operating Officer
Transactions
- Sale
Common Stock
2025-06-09$110.44/sh−25,000$2,761,000→ 5,783 total - Exercise/Conversion
Common Stock
2025-06-09$8.02/sh+25,000$200,500→ 30,783 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-09−25,000→ 0 totalExercise: $8.02From: 2017-05-27Exp: 2026-05-27→ Common Stock (25,000 underlying)
Footnotes (4)
- [F1]Represents an exercise of stock options prior to the 10-year expiration date of such options, which would occur within 12 months.
- [F2]Such transaction was pursuant to a pre-approved 10b5-1 plan.
- [F3]Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
- [F4]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $108.27 and $112.24.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001805812
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 7:00 PM ET
- Size
- 8.7 KB